AU3041700A - Imidazo(4,5-c)-pyridine-4-on-derivatives - Google Patents

Imidazo(4,5-c)-pyridine-4-on-derivatives

Info

Publication number
AU3041700A
AU3041700A AU30417/00A AU3041700A AU3041700A AU 3041700 A AU3041700 A AU 3041700A AU 30417/00 A AU30417/00 A AU 30417/00A AU 3041700 A AU3041700 A AU 3041700A AU 3041700 A AU3041700 A AU 3041700A
Authority
AU
Australia
Prior art keywords
imidazo
pyridine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU30417/00A
Inventor
Soheila Anzali
Sabine Bernotat-Danielowski
Dieter Dorsch
Horst Juraszyk
Werner Mederski
Guido Melzer
Christos Tsaklakidis
Hanns Wurziger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of AU3041700A publication Critical patent/AU3041700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU30417/00A 1999-01-08 1999-12-21 Imidazo(4,5-c)-pyridine-4-on-derivatives Abandoned AU3041700A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19900471A DE19900471A1 (en) 1999-01-08 1999-01-08 Imidazo [4,5c] pyridin-4-one derivatives
DE19900471 1999-01-08
PCT/EP1999/010236 WO2000040583A2 (en) 1999-01-08 1999-12-21 Imidazo[4,5-c]-pyridine-4-on-derivatives

Publications (1)

Publication Number Publication Date
AU3041700A true AU3041700A (en) 2000-07-24

Family

ID=7893790

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30417/00A Abandoned AU3041700A (en) 1999-01-08 1999-12-21 Imidazo(4,5-c)-pyridine-4-on-derivatives

Country Status (16)

Country Link
EP (1) EP1149099A2 (en)
JP (1) JP2002534429A (en)
KR (1) KR20010086085A (en)
CN (1) CN1333772A (en)
AR (1) AR022220A1 (en)
AU (1) AU3041700A (en)
BR (1) BR9916774A (en)
CA (1) CA2357771A1 (en)
CZ (1) CZ20012407A3 (en)
DE (1) DE19900471A1 (en)
HU (1) HUP0105054A3 (en)
NO (1) NO20013384D0 (en)
PL (1) PL349341A1 (en)
SK (1) SK9442001A3 (en)
WO (1) WO2000040583A2 (en)
ZA (1) ZA200106454B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100628407B1 (en) 1998-12-23 2006-09-26 브리스톨-마이어스 스퀴브 파마 컴파니 Nitrogen Containing Heterobicycles as Factor XA Inhibitors
EP1296982B1 (en) * 2000-06-23 2007-09-19 Bristol-Myers Squibb Pharma Company 1-(heteroaryl-phenyl)-condensed pyrazol derivatives as factor xa inhibitors
CA2447488A1 (en) 2001-05-22 2002-11-28 Irina Jacobson Bicyclic inhibitors of factor xa
GB0215293D0 (en) 2002-07-03 2002-08-14 Rega Foundation Viral inhibitors
GB0225399D0 (en) * 2002-10-31 2002-12-11 Merck Sharp & Dohme Therapeutic agents
US7479502B2 (en) 2002-12-03 2009-01-20 Pharmacyclics, Inc. 2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors
EP1706403B9 (en) 2003-12-22 2012-07-25 K.U.Leuven Research & Development Imidazo[4,5-c]pyridine compounds and methods of antiviral treatment
SI1841765T1 (en) 2004-12-21 2009-08-31 Gilead Sciences Inc IMIDAZO?á4,5-C?åPYRIDINE COMPOUND AND METHOD OF ANTIVIRAL TREATMENT
AU2006271781A1 (en) 2005-07-15 2007-01-25 F. Hoffmann-La Roche Ag Novel heteroaryl fused cyclic amines
PL1942898T5 (en) 2005-09-14 2014-10-31 Takeda Pharmaceuticals Co Dipeptidyl peptidase inhibitors for treating diabetes
CN102675221A (en) 2005-09-16 2012-09-19 武田药品工业株式会社 Intermediate in method for preparing pyrimidinedione derivative
WO2007112347A1 (en) 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
MX2009000235A (en) 2006-07-07 2009-01-23 Gilead Sciences Inc Novel pyridazine compound and use thereof.
TW200838536A (en) 2006-11-29 2008-10-01 Takeda Pharmaceutical Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
UA99466C2 (en) 2007-07-06 2012-08-27 Гилиад Сайенсиз, Инк. Crystalline pyridazine compound
BR112017002598B1 (en) * 2014-08-12 2022-03-03 Syngenta Participations Ag Pesticide-active heterocyclic derivatives with sulfur-containing substituents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW219935B (en) * 1991-12-25 1994-02-01 Mitsubishi Chemicals Co Ltd
EP1039907A4 (en) * 1997-12-01 2001-09-19 Merck & Co Inc Thrombin inhibitors

Also Published As

Publication number Publication date
JP2002534429A (en) 2002-10-15
PL349341A1 (en) 2002-07-15
ZA200106454B (en) 2002-11-06
DE19900471A1 (en) 2000-07-13
NO20013384L (en) 2001-07-06
AR022220A1 (en) 2002-09-04
HUP0105054A3 (en) 2002-12-28
CZ20012407A3 (en) 2001-12-12
HUP0105054A2 (en) 2002-05-29
BR9916774A (en) 2001-10-30
WO2000040583A2 (en) 2000-07-13
EP1149099A2 (en) 2001-10-31
CA2357771A1 (en) 2000-07-13
KR20010086085A (en) 2001-09-07
SK9442001A3 (en) 2002-05-09
CN1333772A (en) 2002-01-30
WO2000040583A3 (en) 2000-09-21
NO20013384D0 (en) 2001-07-06

Similar Documents

Publication Publication Date Title
AU3243300A (en) Multiparticulate formulation
AP2006003492A0 (en) Azaindoles.
AU2001259707A1 (en) 6,5-fused bicyclic heterocycles
AU1173201A (en) Skin-gripper
AU3092999A (en) Digital-timeshare-exchange
EP1196417B8 (en) 1,2,3,4,5,6-HEXAHYDROAZEPINO 4,5-b]INDOLES CONTAINING ARYLSULFONES AT THE 9-POSITION
AU3041700A (en) Imidazo(4,5-c)-pyridine-4-on-derivatives
AU5065999A (en) Naphthyridine derivatives
AU3285700A (en) Workbench
AU5691800A (en) Structure
AU2804600A (en) Arylaminoalkylamides
AU2023701A (en) Sketcher
AU2699800A (en) Organoceramics
AU6831500A (en) 1h-pirido[3, 4-b]indol-1-one derivatives
AU2201501A (en) Structure
AU3191100A (en) Ligand-bonded complex
AU1901801A (en) Glucofuranoses
AUPQ009199A0 (en) Wetsuit
AU1915601A (en) Periotome
AU2582200A (en) Windturbine
AU2197301A (en) Microlamp
AU1697601A (en) Seating arrangement
PL352760A1 (en) Oxathiepino[6,5-b
AU1737601A (en) Collectalbum
AU1185700A (en) Armrest

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted